Nkure Therapeutics
1 known investors
NKure develops Natural Killer (NK) cell-based immunotherapies using NK cell and iPSC platforms, pursuing both autologous and allogeneic approaches for cancer and infectious diseases. The company focuses on affordable, scalable cell therapies for patients in India across oncology, autoimmune, and neurodegenerative conditions.
Investors · 1
Frequently asked questions
- What does Nkure Therapeutics do?
- NKure develops Natural Killer (NK) cell-based immunotherapies using NK cell and iPSC platforms, pursuing both autologous and allogeneic approaches for cancer and infectious diseases. The company focuses on affordable, scalable cell therapies for patients in India across oncology, autoimmune, and neurodegenerative conditions.
- Who are Nkure Therapeutics's investors?
- Nkure Therapeutics's investors include Endiya Partners.